We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Quoram | LSE:QRM | London | Ordinary Share | GB00B5M29F66 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.10 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
24/7/2014 18:04 | Please note the following thread which may be of interest: "THE REVERSE TAKEOVERS & SHELLS THREAD (RTO)" | hedgehog 100 | |
20/6/2014 16:11 | are they in the money? | moreforus | |
09/5/2014 12:58 | 40% now and bid ticked up | oilbuy | |
09/5/2014 08:18 | 8% . Well worth buying here !!!! | oilbuy | |
08/5/2014 17:11 | Wsx up 32%. Tara, pls can you get on the case tomorrow | snape | |
11/4/2014 12:22 | Is there anything worth knowing as yet???? perhaps maybe there mght be a disturbance in the bush's??????? then again only imagination...... | maxwell | |
24/3/2014 11:55 | looks good till you read a bit further 2013 2012 Revenue ($'000) 7,455 6,199 Gross profit ($'000) 5,163 3,609 Gross profit margin (%) 69.3 58.2 Operating loss ($'000) (6,946) (6,514) | currypasty | |
24/3/2014 11:41 | Plant Health Care PLC Preliminary Results Alert TIDMPHC RNS Number : 9765C Plant Health Care PLC 24 March 2014 24(th) March 2014 PLANT HEALTH CARE PLC PRELIMINARY RESULTS 2013 Plant Health Care (AIM / CISX: PHC.L), a leading provider of novel patent-protected biological products to the global agriculture markets, announces its preliminary results for the full year ended 31 December 2013. Financial Highlights - Revenues from continuing operations increased by 21% to $7.5m (2012: $6.2m) - 52% growth in Harpin and Myconate sales to $3.8m (2012: $2.5m) - 50% of sales derived from Harpin and Myconate (2012: 41%) - Gross profit increased 44% to $5.2m (2012: $3.6m) - Gross profit margin increased to 69.3% (2012: 58.2%) Operational Highlights - Completion of $20.3m fundraising in April 2013 to invest in the R&D function - Discontinuation of exclusive Monsanto agreement, freeing us to enter agreements with other potential licencees - Agreement with Arysta LifeScience in April 2013 to sell Harpin in combination with certain Arysta products - Positive indications and increased confidence in the potential of third-generation Harpins - Cumulative Harpin treated area exceeded 10m acres around the world - Divestment of Netherlands subsidiary in November 2013 - Following a strategic review, we have retained Plant Health Care Mexico and will continue to operate this profitable subsidiary - New, streamlined head office in North Carolina Paul Schmidt, CEO, commented: "2013 was a year of significant change for Plant Health Care. Following the successful completion of a $20.3m fundraising in April, the Board undertook a strategic review, which resulted in a streamlining and enhanced focus of the business with a substantial increase in R&D investment. Our head office was downsized and relocated to Raleigh, North Carolina, and we divested our Netherlands subsidiary. Our R&D efforts have produced very positive early indicators, particularly for third-generation Harpins, and we are receiving renewed interest from third parties in the possibilities of Myconate. With the creation of a Business Development function, we have enhanced our ability to take existing and future products to market and are starting to deliver new distribution and license agreements, which will drive increased sales. Our R&D team has a world-class level of competence and capabilities in Harpins, as well as in the broader field of plant response elicitors. When I joined Plant Health Care a year ago, the business faced a number of strategic challenges. We have worked hard to overcome those and are now in a very strong position to increase our R&D and commercial efforts in 2014. The potential for Plant Health Care remains very exciting and the Board remains confident of the Company's core technology and the prospects for the business." | moreforus | |
18/3/2014 22:08 | The investment policy is to prop up certain ORA Capital investments. As such PHC is on the balance sheet under investments while WSX (a residual asset from the previous management's investing policy) is 'held for sale' and will likely be sold once the next investment in a ORA-related stock is made. | bam bam rubble | |
18/3/2014 18:20 | If Wsx goes to 1p it could be worth cashing in and moving on. What will management do with PHC ?Why has Griffiths increased his holding to 16%. Will there be excellent news soon ?Management haven't made any right moves yet.Management we offered many a good asset here but all were turned down. In the process shareholder value has not been accomplished. Can they pull a rabbit out of a hat ???Time will tell | oilbuy | |
18/3/2014 10:47 | Bitter and twisted.So who is right The chap who buys as you sell for a massive loss, or the shareholder who paid 10 times more years ago.? | tara7 | |
18/3/2014 10:38 | Anyone suckered into buying these at any price will lose money.... remember when brought to the market under another name and direction 5+ years ago.. The share price was 4p then 6p & then 12p and then dropping fast to 4p and forever downward since. A 10 bagger at current price will not return 25% of money spent as it will need a 30+ bagger and that will never happen with the current leaders. | maxwell | |
18/3/2014 09:40 | Never mind the past shares are about next week and month and year.One should buy when others will not or do not.Free cash here. | tara7 | |
18/3/2014 09:28 | so, on a 1.3m mcap company, they made a loss of £800k | currypasty | |
18/3/2014 08:42 | The market dropped on a buy...market makers are treating the co with disdain.... | moreforus | |
18/3/2014 07:59 | well market is gonna open flat.... | moreforus | |
18/3/2014 07:55 | For any new investor buying at the right price today is in my view low risk. For a start both investments could do very well. Then each pound of cash costs less than each share. Then great chance of an RTO. THUS IN MY VIEW THE SHARES SHOULD TRADE AT ABOVE THOSE VALUES IE DOUBLE TODAYS PRICE. ANY DEAL COULD SEE THEM 2,4, 6, 8, or 10 bag over time from a very very low base. | tara7 | |
18/3/2014 07:50 | It's all well and good having cash. It's also very easy to throw away.PHC share price has come back a little though. Richard Griffiths has taken from memory 16% of PHC. I am not over confident with management here but will stay invested and see if this plays out on a positive note. | oilbuy | |
18/3/2014 07:43 | what are they gonna do with the cash? and they generated some income from cleaning next doors windows too. | moreforus | |
18/3/2014 07:39 | After today's results you can still buy these shares for less than cash on the books! You also get shares in two other companies. You also get a lump of what is in effect a cash shell. That is in my view low risk with a good chance of a very high return over the next two years. | tara7 |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions